Management of ovarian functions by melatonin
Open Access
- 19 April 2021
- journal article
- Published by Scientific Scholar
- Vol. 2, 16
- https://doi.org/10.25259/jrhm_39_2020
Abstract
Extensive research has unraveled a niche for melatonin that is of great significance for the female reproductive physiology. The potency of melatonin as an antioxidant, anti-inflammatory, and anti-apoptotic agent is being utilized to benefit female reproductive anomalies. Melatonin receptors have been localized in the Supra Chaismatic Nucleus (SCN), pars tuberalis (PT), and the gonads suggesting the regulation of reproduction by melatonin not only at a higher level but also on the gonads through complex interrelated mechanisms. Melatonin secreted by the pineal gland acts on the hypothalamus to regulate gonadotropin-releasing hormone and subsequently gonadotropin (FSH/LH) release from the PT. However, the de novo synthesis of this indoleamine reported in the gonads gave rise to the idea of a more localized action. The mammalian ovary has all the molecular machinery required for the biosynthesis of melatonin and interestingly concentration of melatonin in the follicular fluid of pre-ovulatory follicles is much higher than circulatory melatonin even in humans. This locally produced melatonin has been shown to modulate various pathways governing ovarian steroidogenesis. Further, melatonin and its receptors play a significant role in antioxidant defense mechanism of ovary for follicular growth and maturation. Exposure to stress strongly influences hypothalamic-pituitary-adrenal axis and elevated glucocorticoid levels suppress various ovarian functions including implantation thereby pregnancy. Melatonin acts antagonistically with glucocorticoids, making it crucial for the management of the female reproductive functions/dysfunctions. Usage of melatonin during in vitro fertilization (IVF) procedures has been found to improve oocyte quality, survival, and fecundity. Therefore, in future, melatonin can be implicated as preferable therapeutic especially in IVF and assisted reproductive techniques.Keywords
This publication has 76 references indexed in Scilit:
- Circadian Control of Kisspeptin and a Gated GnRH Response Mediate the Preovulatory Luteinizing Hormone SurgeEndocrinology, 2010
- International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, Classification, and Pharmacology of G Protein-Coupled Melatonin ReceptorsPharmacological Reviews, 2010
- Modulation ofin vivooxidative status by exogenous corticosterone and restraint stress in ratsStress, 2009
- Bidirectional communication between the pineal gland and the immune systemCanadian Journal of Physiology and Pharmacology, 2003
- Serotoninergic and melatoninergic systems are fully expressed in human skinThe FASEB Journal, 2002
- Growth hormone secretion: The role of glucocorticoidsLife Sciences, 1994
- Suppression of the Hypothalamic-Pituitary-Ovarian Axis in Normal Women by Glucocorticoids1Biology of Reproduction, 1993
- Immunosuppressive Levels of Glucocorticoid Block Extrauterine Luteolysins in the Rat1Biology of Reproduction, 1993
- Lesions of the Suprachiasmatic Nucleus Indicate the Presence of a Direct Vasoactive Intestinal Polypeptide‐Containing Projection to Gonadotrophin‐Releasing Hormone Neurons in the Female RatJournal of Neuroendocrinology, 1993
- ISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES1Journal of the American Chemical Society, 1958